Re-energized Akzo Nobel Seeks Acquisitions

Akzo Nobel is refocusing and gearing up for growth following the previously announced sale of its pharmaceuticals business to Schering-Plough, for which Akzo will receive about €11 billion ($14.7 billion). Akzo has become a “new organization” with proforma sales in 2006 of $13.3 billion, excluding pharmaceuticals, split 60-40 between coatings and chemicals, says Hans Wijers, CEO. Wijers was speaking at a journalists’ briefing in Shanghai last week, where he announced a doubling of Akzo’s sales target for China (p. 11). Wijers: Moving...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers